These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 10692582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    Jacobsson SO, Fowler CJ.
    Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade.
    Maccarrone M, Salvati S, Bari M, Finazzi-Agró.
    Biochem Biophys Res Commun; 2000 Nov 30; 278(3):576-83. PubMed ID: 11095952
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
    Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A.
    Proc Natl Acad Sci U S A; 1995 Apr 11; 92(8):3376-80. PubMed ID: 7724569
    [Abstract] [Full Text] [Related]

  • 8. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
    Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A.
    Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):3984-9. PubMed ID: 8633002
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R, Ho WS, Bottrill FE, Ford WR, Hiley CR.
    Br J Pharmacol; 2001 Oct 30; 134(4):921-9. PubMed ID: 11606334
    [Abstract] [Full Text] [Related]

  • 10. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
    Lau AH, Chow SS.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):229-35. PubMed ID: 12620517
    [Abstract] [Full Text] [Related]

  • 11. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S, Jonsson KO, Fowler CJ, Lambert DM.
    J Med Chem; 2003 Apr 10; 46(8):1440-8. PubMed ID: 12672243
    [Abstract] [Full Text] [Related]

  • 12. Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages.
    Maccarrone M, Attinà M, Bari M, Cartoni A, Ledent C, Finazzi-Agrò A.
    J Neurochem; 2001 Jul 10; 78(2):339-48. PubMed ID: 11461969
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
    Tiger G, Stenström A, Fowler CJ.
    Biochem Pharmacol; 2000 Mar 15; 59(6):647-53. PubMed ID: 10677581
    [Abstract] [Full Text] [Related]

  • 14. Anandamide activates human platelets through a pathway independent of the arachidonate cascade.
    Maccarrone M, Bari M, Menichelli A, Del Principe D, Agrò AF.
    FEBS Lett; 1999 Mar 26; 447(2-3):277-82. PubMed ID: 10214961
    [Abstract] [Full Text] [Related]

  • 15. Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.
    Thors L, Fowler CJ.
    Eur J Pharmacol; 2009 Oct 25; 621(1-3):10-8. PubMed ID: 19715690
    [Abstract] [Full Text] [Related]

  • 16. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF, Hillard CJ, Edgemond WS, Campbell WB.
    Am J Physiol; 1998 Jan 25; 274(1):H375-81. PubMed ID: 9458889
    [Abstract] [Full Text] [Related]

  • 17. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V.
    Fundam Clin Pharmacol; 2002 Aug 25; 16(4):297-302. PubMed ID: 12570018
    [Abstract] [Full Text] [Related]

  • 18. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
    Fowler CJ, Jacobsson SO.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Aug 25; 66(2-3):193-200. PubMed ID: 12052035
    [Abstract] [Full Text] [Related]

  • 19. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
    De Petrocellis L, Davis JB, Di Marzo V.
    FEBS Lett; 2001 Oct 12; 506(3):253-6. PubMed ID: 11602256
    [Abstract] [Full Text] [Related]

  • 20. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L.
    FEBS Lett; 1998 Oct 09; 436(3):449-54. PubMed ID: 9801167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.